17 March 2021
On the other side of Brexit and in the midst of a pandemic, the UK’s domestic regulator of medicines and healthcare now stands alone for the first time in almost 40 years.
Writing in NLJ this week, Sarah Moore and Stuart Warmington explore the long-term shape of medicine and medical device regulation in the UK.
Among the changes on the horizon is the creation of a new statutory role, the independent patient safety commissioner, who will work to promote patient safety and ensure that patients’ views are heard.
RELATED ARTICLES
